This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

Karo Healthcare wins conditional Norwegian approval to buy Aco Hud Nordic

( March 6, 2026, 13:05 GMT | Official Statement) -- MLex Summary: Norway's competition authority has said that Karo Healthcare may acquire Aco Hud Nordic, on condition it divests the rights to market and sell Locobase-branded products to an independent buyer. Karo and Aco Hud overlap in the supply of therapeutic skincare products, and the watchdog found that the deal would remove the current competitive pressure between them. The deal cannot be completed until the authority has approved both the buyer and the sale agreements.Statement follows. ...

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login